Pleural Fluid Analysis Parameters

Essential Initial Parameters

• The British Thoracic Society recommends that all pleural fluid samples should be analyzed for protein, lactate dehydrogenase (LDH), pH, glucose, cytology, Gram stain, acid-fast bacilli (AAFB) stain, and sent for microbiological culture in both sterile vials and blood culture bottles 1
• Gross appearance and odor must be documented in every case, as this provides immediate diagnostic clues, such as purulent appearance suggesting empyema, or unpleasant odor indicating anaerobic infection 1, 2
• Protein and LDH levels, both pleural fluid and serum, should be measured to apply Light's criteria for transudate vs. exudate differentiation 1, 2
• Cytology should be sent on all exudative effusions, though it only diagnoses 60% of malignant effusions, and if first cytology is non-diagnostic, a second sample should be obtained to increase diagnostic yield 1, 2, 3

Context-Specific Parameters

• For suspected parapneumonic effusion or infection, pH measurement is mandatory and should be performed immediately in all non-purulent effusions, with a pH ≤7.2 indicating high risk of complicated parapneumonic effusion/empyema requiring chest tube drainage 4, 2
• In cases of suspected parapneumonic effusion or infection, glucose level can be used if pH is unavailable, with glucose <3.3 mmol/L suggesting high probability of complicated parapneumonic effusion/empyema 4
• LDH >900 IU/L in intermediate-risk cases (pH 7.2-7.4) warrants chest tube consideration, especially with fever, high fluid volume, low glucose, or septations on ultrasound 4
• For suspected tuberculosis, lymphocyte-predominant exudate with positive tuberculin skin test justifies empirical anti-TB therapy 5, 2
• For suspected malignancy, cytology has only 60% sensitivity, and if negative and malignancy is suspected, image-guided pleural biopsy or thoracoscopy should be considered 1
• For suspected heart failure, serum NT-proBNP should be measured for unilateral effusions suspected of cardiac origin, as pleural fluid NT-proBNP offers no advantage over serum levels 4
• Pleural fluid ANA may support lupus pleuritis diagnosis, though 10% of non-SLE effusions are ANA-positive 4, 3
• Haematocrit should be measured if grossly bloody to diagnose hemothorax 1

Critical Clinical Pitfalls

• The American College of Chest Physicians recommends that bilateral effusions should not be aspirated in clinically obvious transudates unless atypical features are present or there is failure to respond to therapy 6
• Pulmonary embolism and tuberculosis should be reconsidered in persistently undiagnosed effusions, as these have specific treatments 5, 2
• Contrast-enhanced CT with fluid present should be performed before complete drainage to optimize pleural visualization and identify biopsy targets 1
• Blind pleural biopsies should be avoided, and image-guided techniques or thoracoscopy should be used instead 4

Classification of Pleural Effusions

Diagnostic Criteria

• Light's criteria classify a pleural effusion as an exudate if it meets at least one of the following: pleural fluid to serum protein ratio >0.5, pleural fluid to serum LDH ratio >0.6, or pleural fluid LDH >0.67 of the upper limit of normal serum value 7, 8, 9
• The European Respiratory Society recommends using Light's criteria to differentiate between transudative and exudative pleural effusions, with excellent sensitivity (98%) but lower specificity (72%) for identifying exudative effusions 7, 8

Performance Characteristics

• The positive likelihood ratio of Light's criteria is 3.5 and the negative likelihood ratio is 0.03, indicating a high probability of exudative effusion when the criteria are met 7
• These criteria were designed to maximize detection of exudates to avoid missing potentially serious conditions like malignancy or infection, with a strength of evidence supporting their use 7, 8

Alternative Approaches

• If serum samples are not available, an alternative approach is using an "or" rule, which has been shown to have discriminative capacity equivalent to Light's criteria 7, 8

Clinical Implications

• Correct classification of pleural effusions guides further diagnostic workup and management, with exudative effusions typically requiring more extensive investigation for underlying causes such as malignancy, infection, or inflammatory conditions 10
• The American Thoracic Society suggests that pleural fluid pH is a better discriminator than glucose in pleural infection, highlighting the importance of accurate diagnosis 10

Diagnostic Criteria for Pleural Effusions

Laboratory Parameters

• The British Thoracic Society recommends measuring pleural fluid and serum samples for protein levels and lactate dehydrogenase (LDH) levels to classify pleural effusions 11, 12
• Pleural fluid pH <7.2 suggests complicated parapneumonic effusion, empyema, rheumatoid arthritis, esophageal rupture, or malignancy 11, 12
• Pleural glucose <3.3 mmol/L suggests empyema, rheumatoid disease, lupus, tuberculosis, malignancy, or esophageal rupture 11, 12
• Elevated pleural fluid amylase (higher than serum or pleural/serum ratio >1.0) suggests pancreatitis, esophageal rupture, or malignancy 11

Diagnosis and Management of Exudative Pleural Effusions

1. Thoracentesis Technique and Initial Fluid Handling

• Perform diagnostic thoracentesis with a 21‑gauge needle and a 50 mL syringe to obtain pleural fluid for analysis. 13
• Immediately document the gross appearance and odor of the fluid:
  
  • Purulent → suggests empyema
  • Milky → suggests chylothorax
  • Bloody → raises suspicion for malignancy, pulmonary embolism, trauma, or other hemorrhagic causes
  • Unpleasant odor → suggests anaerobic infection. 13
• If the fluid is turbid or milky, centrifuge it: a clear supernatant after centrifugation favors empyema (cell debris), whereas persistent turbidity suggests chylothorax or pseudo‑chylothorax. [13][14]
• For grossly bloody fluid, measure pleural‑fluid hematocrit: a value > 50 % of the peripheral blood hematocrit confirms hemothorax; a value < 1 % indicates clinically insignificant blood. [13][14]

2. Mandatory Pleural‑Fluid Laboratory Tests

• Send every sample for biochemistry (protein, lactate dehydrogenase, pH, glucose). [13][15]
• Send for microbiology (Gram stain, acid‑fast bacilli stain, culture in sterile vials and blood‑culture bottles – the latter improves diagnostic yield). [13][15]
• Send for cytology (cell count, differential, and malignant‑cell evaluation). 13

3. Interpretation of Specific Findings

3.1. Parapneumonic Effusion / Empyema

• Measure pleural‑fluid pH promptly when infection is suspected; a pH ≤ 7.2 identifies a complicated parapneumonic effusion or empyema that requires chest‑tube drainage. 13

3.2. Malignancy

• Cytology detects malignancy in approximately 60 % of malignant effusions. [13][15]
• Grossly bloody fluid is frequently associated with malignancy, pulmonary embolism with infarction, trauma, benign asbestos‑related effusions, or post‑cardiac‑injury syndrome. 14

3.3. Tuberculosis

• For suspected tuberculous effusion, obtain AAFB stain and mycobacterial culture from both sterile vials and blood‑culture bottles to maximize yield. [13][15]

4. Advanced Imaging and Tissue Diagnosis

4.1. Contrast‑Enhanced CT Thorax

• When pleural‑fluid analysis and clinical data are nondiagnostic, obtain a contrast‑enhanced CT scan with the effusion still present; this improves visualization of the pleura and helps select optimal sites for pleural biopsy. [13][15]

4.2. Pleural Biopsy

• If cytology is negative and the exudative effusion remains unexplained, perform an ultrasound‑ or CT‑guided pleural biopsy or thoracoscopy (blind biopsies should be avoided). [13][15]
• Send biopsy tissue for histopathology and mycobacterial culture, and repeat pleural aspiration for cytology and microbiology. [13][15]

5. Practical Pitfalls to Avoid

• Always place pleural fluid in both sterile vials and blood‑culture bottles; this practice increases microbiological diagnostic yield. [13][15]

All statements are derived from peer‑reviewed sources (Thorax, 2003) and reflect the current evidence base for the evaluation of exudative pleural effusions.